Clorox (NYSE:CLX) Reaches New 52-Week Low – What’s Next?

The Clorox Company (NYSE:CLX) hit a new 52-week low on Monday . The company traded as low as $105.24 and last traded at $105.1410, with a volume of 217803 shares changing hands. The stock had previously closed at $107.36.

Analysts Set New Price Targets

A number of brokerages have recently commented on CLX. Wells Fargo & Company cut their price objective on Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a research report on Tuesday, November 4th. UBS Group set a $119.00 price target on Clorox and gave the company a “neutral” rating in a research report on Tuesday, November 4th. Bank of America dropped their price target on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 8th. Barclays reduced their price objective on shares of Clorox from $112.00 to $108.00 and set an “underweight” rating for the company in a research note on Tuesday, November 4th. Finally, TD Cowen dropped their target price on shares of Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a research report on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $125.69.

Clorox Price Performance

The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a market cap of $12.71 billion, a price-to-earnings ratio of 15.99, a PEG ratio of 0.92 and a beta of 0.52. The business has a fifty day moving average price of $119.49 and a 200 day moving average price of $124.72.

Clorox (NYSE:CLX) last posted its earnings results on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business’s quarterly revenue was down 18.9% on a year-over-year basis. During the same period last year, the company earned $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, research analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd were issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date was Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is currently 77.86%.

Insiders Place Their Bets

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.63% of the company’s stock.

Institutional Trading of Clorox

Several institutional investors and hedge funds have recently modified their holdings of the business. Koshinski Asset Management Inc. increased its position in shares of Clorox by 7.3% during the 3rd quarter. Koshinski Asset Management Inc. now owns 1,857 shares of the company’s stock valued at $229,000 after purchasing an additional 127 shares during the last quarter. Inspire Trust Co. N.A. increased its position in shares of Clorox by 10.7% in the third quarter. Inspire Trust Co. N.A. now owns 31,000 shares of the company’s stock valued at $3,822,000 after acquiring an additional 3,000 shares during the period. Advisors Preferred LLC bought a new position in Clorox during the 3rd quarter valued at approximately $236,000. Lansforsakringar Fondforvaltning AB publ raised its holdings in Clorox by 0.5% in the 3rd quarter. Lansforsakringar Fondforvaltning AB publ now owns 41,395 shares of the company’s stock worth $5,104,000 after purchasing an additional 222 shares in the last quarter. Finally, Advyzon Investment Management LLC bought a new position in shares of Clorox in the 3rd quarter worth about $216,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.